Systematic Review

Published on 02 Mar 2023

A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Athéna Crespin
Clément Le Bescop
Jean de Gunzburg
Fabien Vitry
Gérard Zalcman
Julie Cervesi
Pierre-Alain Bandinelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1075593

4,608 views
16 citations

Case Report

Published on 01 Mar 2023

Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden

in Cancer Immunity and Immunotherapy

Mengyao Dai
Jianpeng Sheng
Qi Zhang
Jianxin Wang
Qihan Fu
Tingbo Liang

Frontiers in Oncology

doi 10.3389/fonc.2023.1118633

2,072 views

Original Research

Published on 28 Feb 2023

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma

in Cancer Immunity and Immunotherapy

Fang Zhang
Yali Wang
Hongjuan Li
Li Li
Xiaofeng Yang
Xiaoyan You
Lina Tang

Frontiers in Oncology

doi 10.3389/fonc.2023.1118906

2,684 views
4 citations

Systematic Review

Published on 28 Feb 2023

Baseline risk factors associated with immune related adverse events and atezolizumab

in Cancer Immunity and Immunotherapy

Katrin Madjar
Rajat Mohindra
Gonzalo Durán-Pacheco
Rashad Rasul
Laurent Essioux
Vidya Maiya
G. Scott Chandler

Frontiers in Oncology

doi 10.3389/fonc.2023.1138305

3,897 views
6 citations

Original Research

Published on 27 Feb 2023

JAG1 is correlated to suppressive immune microenvironment and predicts immunotherapy resistance in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Jing He
Lu Li
Lulu Lv
Xiaoyan Chen
Minghui Ge
Yong Ren
Xinyu Tang
Ping Liu
Wen Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1091488

2,288 views
2 citations

Original Research

Published on 24 Feb 2023

Invasion characteristics and clinical significance of tumor-associated macrophages in gastrointestinal Krukenberg tumors

in Cancer Immunity and Immunotherapy

Zigao Huang
Baojia Li
Haiquan Qin
Xianwei Mo

Frontiers in Oncology

doi 10.3389/fonc.2023.1006183

2,013 views
4 citations

Original Research

Published on 23 Feb 2023

Global research trends between gut microbiota and lung cancer from 2011 to 2022: A bibliometric and visualization analysis

in Cancer Immunity and Immunotherapy

Haitao Chen
Yuebiao Lai
Chenxiao Ye
Changhong Wu
Jiali Zhang
Zewei Zhang
Qinghua Yao

Frontiers in Oncology

doi 10.3389/fonc.2023.1137576

3,094 views
9 citations

Original Research

Published on 22 Feb 2023

Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatments

in Cancer Immunity and Immunotherapy

Chiara Piubelli
Matteo Valerio
Matteo Verzè
Fabrizio Nicolis
Carlotta Mantoan
Sonia Zamboni
Francesca Perandin
Eleonora Rizzi
Stefano Tais
Monica Degani

Frontiers in Oncology

doi 10.3389/fonc.2023.1089944

1,188 views

Review

Published on 21 Feb 2023

Cell adhesion molecules and immunotherapy in advanced non-small cell lung cancer: Current process and potential application

in Cancer Immunity and Immunotherapy

Hongjian Yang
Yuxi Miao
Zhaojin Yu
Minjie Wei
Xue Jiao

Frontiers in Oncology

doi 10.3389/fonc.2023.1107631

2,837 views
1 citation

Editorial

Published on 17 Feb 2023

Editorial: Plasticity of immune cells in tumor microenvironment

in Cancer Immunity and Immunotherapy

Valentyn Oksenych

Frontiers in Oncology

doi 10.3389/fonc.2023.1160961

1,723 views

Systematic Review

Published on 16 Feb 2023

The immunotherapy advancement targeting malignant blastomas in early childhood

in Cancer Immunity and Immunotherapy

Bolun Zang
Luyue Ding
Linlin Liu
Senthil Arun Kumar
Wei Liu
Chongchen Zhou
Yongtao Duan

Frontiers in Oncology

doi 10.3389/fonc.2023.1015115

1,999 views

Original Research

Published on 10 Feb 2023

Knockout of ENO1 leads to metabolism reprogramming and tumor retardation in pancreatic cancer

in Cancer Immunity and Immunotherapy

Qingru Song
Kai Zhang
Tianjiao Sun
Congcong Xu
Wei Zhao
Zhiqian Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1119886

4,681 views
9 citations

Original Research

Published on 09 Feb 2023

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma

in Cancer Immunity and Immunotherapy

Ann W. Silk
Brendan Curti
Jennifer Bryan
Tracie Saunders
Weichung Shih
Michael P. Kane
Phoebe Hannon
Christopher Fountain
Jessica Felcher
Andrew Zloza

Frontiers in Oncology

doi 10.3389/fonc.2023.1108341

3,040 views
7 citations

Original Research

Published on 09 Feb 2023

Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Nikita Dutta
Anna Rohlin
Ella A. Eklund
Maria K. Magnusson
Frida Nilsson
Levent M. Akyürek
Per Torstensson
Volkan I. Sayin
Anna Lundgren
Andreas Hallqvist

Frontiers in Oncology

doi 10.3389/fonc.2022.1073457

2,663 views
1 citation

Original Research

Published on 02 Feb 2023

Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer

in Cancer Immunity and Immunotherapy

Jiale Gao
Xiao Zhang
Zhengyang Yang
Jie Zhang
Zhigang Bai
Wei Deng
Guangyong Chen
Rui Xu
Qi Wei
Yishan Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1057947

2,690 views
10 citations

Review

Published on 02 Feb 2023

Tumor−associated macrophage polarization in the inflammatory tumor microenvironment

in Cancer Immunity and Immunotherapy

Zijuan Zou
Hongfen Lin
Mengsen Li
Bo Lin

Frontiers in Oncology

doi 10.3389/fonc.2023.1103149

7,751 views
29 citations

Navigation group

Articles

A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors

Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma

Baseline risk factors associated with immune related adverse events and atezolizumab

JAG1 is correlated to suppressive immune microenvironment and predicts immunotherapy resistance in lung adenocarcinoma

Invasion characteristics and clinical significance of tumor-associated macrophages in gastrointestinal Krukenberg tumors

Global research trends between gut microbiota and lung cancer from 2011 to 2022: A bibliometric and visualization analysis

Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatments

Cell adhesion molecules and immunotherapy in advanced non-small cell lung cancer: Current process and potential application

Editorial: Plasticity of immune cells in tumor microenvironment

The immunotherapy advancement targeting malignant blastomas in early childhood

Knockout of ENO1 leads to metabolism reprogramming and tumor retardation in pancreatic cancer

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma

Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer

Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer

Tumor−associated macrophage polarization in the inflammatory tumor microenvironment